Executive Summary
In this appeal action for revocation, the UPC Court of Appeal granted a stay of proceedings upon request by Juul Labs International, Inc., pending the outcome of parallel opposition proceedings at the EPO Boards of Appeal. The court determined that since the EPO proceedings were accelerated and expected to conclude rapidly relative to the UPC's hearing schedule, staying the appeal was appropriate under R. 295(a) RoP. This decision highlights the practical mechanism for managing concurrent litigation between the Unified Patent Court and the European Patent Office.
What the Court Held — Ratio Decidendi
The Court of Appeal applied R. 295(a) RoP to grant a stay because the parallel opposition proceedings before the EPO Boards of Appeal were expected to result in a rapid decision, aligning with the timeline for an oral hearing before the UPC. This demonstrates the court's willingness to coordinate procedures between the UPC and national/EPO bodies when efficiency is paramount.
Practitioner Note
This decision granted relief to the petitioner. If you are facing a similar patent dispute before Luxembourg (LU), this precedent supports interim or final relief where the facts are comparable. The ratio regarding the applied tests is particularly relevant for strategy.
Related Cases
Network System Technologies LLCvsVolkswagen AG
In this procedural matter before the UPC Court of Appeal, Network System Technologies LLC sought the release of substantial security deposits previously ordered by the Munich Local Division. The security had been required to cover potential legal costs related to infringement proceedings against Volkswagen AG. Crucially, NTS subsequently withdrew its infringement actions at the lower court level. The Court of Appeal agreed that with the withdrawal of the main claims, the basis for maintaining the security vanished. This decision provides a clear procedural precedent regarding the timely release of funds when underlying litigation is terminated by the claimant.
Sun Patent TrustvsVivo Mobile Communication Co., Ltd.
This procedural order addressed a request by VIVO to stay the main infringement proceedings and grant an extension of time limits in light of pending appeals regarding confidentiality orders and jurisdictional challenges (PO). The Court of Appeal ultimately rejected this request, emphasizing strict adherence to the Rules of Procedure. The ruling reinforces that specialized provisions like R. 21.2 RoP are narrowly construed and that procedural management requests must generally be directed to the Court of First Instance.
UERAN Technology LLCvsXiaomi Corporation, Xiaomi Communications Co., Ltd., Xiaomi Inc., Xiaomi Technology Netherlands B.V., Xiaomi Technology Germany GmbH, Xiaomi Technology France S.A.S., Xiaomi Technology Italy S.R.L.
This entry represents a case file involving UERAN Technology LLC against Xiaomi Corporation. However, the provided text is merely an excerpt showing the signatures and dates of the involved parties' counsel and judges/participants. Consequently, no substantive information regarding the infringement claims, patent scope, or final judgment can be determined from this snippet.
Lionra Technologies Ltd.vsCisco Systems GmbH and Cisco Systems, Inc.
In a procedural ruling concerning costs determination in UPC case UPC_CFI_58/2024, Lionra Technologies Ltd. successfully petitioned for restoration of its previous status after missing a deadline under Rule 151 VerfO. The court accepted the argument that the oversight was an organizational error within the claimant's legal team, which fell outside the party's control. This decision reinforces the principle that procedural deadlines, especially those related to costs procedures, can be restored if the failure is attributable to circumstances beyond the party's reasonable influence.
Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Groupe S.A., and Sanofi Winthrop Industrie S.A.vsAmgen, Inc
This decision from the UPC Court of Appeal concerns procedural matters, specifically the withdrawal of applications for rehearing in a complex dispute involving Sanofi and Amgen over patent EP 3 666 797. Following earlier proceedings where the Central Division had revoked the patent, both parties engaged in appeals and subsequent requests for rehearing. Ultimately, the Court permitted the withdrawal of these procedural actions upon consent from all involved parties. This case highlights how UPC courts manage complex litigation pathways when parties agree to terminate specific stages of the legal process.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.